Keywords
Last Name
Institution

Charles A. Powell

TitlePROFESSOR
InstitutionMount Sinai
DepartmentPulmonary, Critical Care and Sleep Medicine
Address5 E. 98th Street
8th Floor
New York NY 10029
Phone212-241-5656
Fax212-241-8866

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gaga M, Powell CA, Schraufnagel DE, Schönfeld N, Rabe K, Hill NS, Sculier JP. An official American Thoracic Society/European Respiratory Society statement: the role of the pulmonologist in the diagnosis and management of lung cancer. Am J Respir Crit Care Med. 2013 Aug 15; 188(4):503-7.
      View in: PubMed
    2. Powell CA, Halmos B, Nana-Sinkam SP. Update in lung cancer and mesothelioma 2012. Am J Respir Crit Care Med. 2013 Jul 15; 188(2):157-66.
      View in: PubMed
    3. Nana-Sinkam SP, Powell CA. Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e30S-9S.
      View in: PubMed
    4. Bergamo C, Lin JJ, Smith C, Lurslurchachai L, Halm EA, Powell CA, Berman A, Schicchi JS, Keller SM, Leventhal H, Wisnivesky JP. Evaluating beliefs associated with late-stage lung cancer presentation in minorities. J Thorac Oncol. 2013 Jan; 8(1):12-8.
      View in: PubMed
    5. Cheng H, Zhang Z, Borczuk A, Powell CA, Balajee AS, Lieberman HB, Halmos B. PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells. Carcinogenesis. 2013 Apr; 34(4):739-49.
      View in: PubMed
    6. Jonnalagadda S, Lin JJ, Nelson JE, Powell CA, Salazar-Schicchi J, Berman AR, Keller SM, Smith CB, Lurslurchachai L, Halm EA, Leventhal H, Wisnivesky JP. Racial and ethnic differences in beliefs about lung cancer care. Chest. 2012 Nov; 142(5):1251-8.
      View in: PubMed
    7. Shu C, Cheng H, Wang A, Mansukhani MM, Powell CA, Halmos B, Borczuk AC. Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung. Mod Pathol. 2013 Feb; 26(2):239-46.
      View in: PubMed
    8. Bulman W, Saqi A, Powell CA. Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy. Am J Respir Crit Care Med. 2012 Mar 15; 185(6):606-11.
      View in: PubMed
    9. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Powell CA, Beer D, Riely G, Garg K, Austin JH, Rusch VW, Hirsch FR, Jett J, Yang PC, Gould M. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc. 2011 Sep; 8(5):381-5.
      View in: PubMed
    10. Halmos B, Powell CA. Update in lung cancer and oncological disorders 2010. Am J Respir Crit Care Med. 2011 Aug 1; 184(3):297-302.
      View in: PubMed
    11. Smith CB, Nelson JE, Berman AR, Powell CA, Fleischman J, Salazar-Schicchi J, Wisnivesky JP. Lung cancer physicians' referral practices for palliative care consultation. Ann Oncol. 2012 Feb; 23(2):382-7.
      View in: PubMed
    12. Yatabe Y, Borczuk AC, Powell CA. Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer. 2011 Oct; 74(1):7-11.
      View in: PubMed
    13. Nelson JE, Gay EB, Berman AR, Powell CA, Salazar-Schicchi J, Wisnivesky JP. Patients rate physician communication about lung cancer. Cancer. 2011 Nov 15; 117(22):5212-20.
      View in: PubMed
    14. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011 Feb; 6(2):244-85.
      View in: PubMed
    15. Arlen AM, Powell CR, Kreder KJ. Sacral neuromodulation for refractory urge incontinence is less effective following spinal surgery. ScientificWorldJournal. 2011; 11:142-6.
      View in: PubMed
    16. Wilgus ML, Borczuk AC, Stoopler M, Ginsburg M, Gorenstein L, Sonett JR, Powell CA. Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer. 2011 May 15; 117(10):2186-91.
      View in: PubMed
    17. Cheng H, Xu X, Costa DB, Powell CA, Halmos B. Molecular testing in lung cancer: the time is now. Curr Oncol Rep. 2010 Sep; 12(5):335-48.
      View in: PubMed
    18. Daniels DH, Powell CR, Braasch MR, Kreder KJ. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn. 2010 Apr; 29(4):578-81.
      View in: PubMed
    19. Travis WD, Rekhtman N, Riley GJ, Geisinger KR, Asamura H, Brambilla E, Garg K, Hirsch FR, Noguchi M, Powell CA, Rusch VW, Scagliotti G, Yatabe Y. Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol. 2010 Apr; 5(4):411-4.
      View in: PubMed
    20. Toonkel RL, Borczuk AC, Powell CA. Tgf-beta signaling pathway in lung adenocarcinoma invasion. J Thorac Oncol. 2010 Feb; 5(2):153-7.
      View in: PubMed
    21. Wisnivesky JP, Halm E, Bonomi M, Powell C, Bagiella E. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med. 2010 Feb 1; 181(3):264-9.
      View in: PubMed
    22. Dubey S, Powell CA. Update in lung cancer 2008. Am J Respir Crit Care Med. 2009 May 15; 179(10):860-8.
      View in: PubMed
    23. Borczuk AC, Qian F, Kazeros A, Eleazar J, Assaad A, Sonett JR, Ginsburg M, Gorenstein L, Powell CA. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol. 2009 Mar; 33(3):462-9.
      View in: PubMed
    24. Austin JH, Mujoomdar A, Powell CA, Pearson GD, Raftopoulos H. Carcinoma of the lung and metastatic disease of the central nervous system. Am J Respir Crit Care Med. 2008 Nov 15; 178(10):1090; author reply 1090.
      View in: PubMed
    25. Mesia-Vela S, Yeh CC, Austin JH, Dounel M, Powell CA, Reeves A, Santella RM, Stevenson L, Yankelevitz D, Barr RG. Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers. Biomarkers. 2008 Jun; 13(4):422-34.
      View in: PubMed
    26. Dubey S, Powell CA. Update in lung cancer 2007. Am J Respir Crit Care Med. 2008 May 1; 177(9):941-6.
      View in: PubMed
    27. Powell CA. Waiting to exhale. Am J Respir Crit Care Med. 2008 Feb 1; 177(3):246-7.
      View in: PubMed
    28. Yeh CC, Barr RG, Powell CA, Mesia-Vela S, Wang Y, Hamade NK, Austin JH, Santella RM. No effect of cigarette smoking dose on oxidized plasma proteins. Environ Res. 2008 Feb; 106(2):219-25.
      View in: PubMed
    29. Dubey S, Powell CA. Update in lung cancer 2006. Am J Respir Crit Care Med. 2007 May 1; 175(9):868-74.
      View in: PubMed
    30. Mujoomdar A, Austin JH, Malhotra R, Powell CA, Pearson GD, Shiau MC, Raftopoulos H. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology. 2007 Mar; 242(3):882-8.
      View in: PubMed
    31. Borczuk AC, Powell CA. Expression profiling and lung cancer development. Proc Am Thorac Soc. 2007 Jan; 4(1):127-32.
      View in: PubMed
    32. Borczuk AC, Cappellini GC, Kim HK, Hesdorffer M, Taub RN, Powell CA. Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors. Oncogene. 2007 Jan 25; 26(4):610-7.
      View in: PubMed
    33. Foronjy RF, Mercer BA, Maxfield MW, Powell CA, D'Armiento J, Okada Y. Structural emphysema does not correlate with lung compliance: lessons from the mouse smoking model. Exp Lung Res. 2005 Jul-Aug; 31(6):547-62.
      View in: PubMed
    34. Borczuk AC, Kim HK, Yegen HA, Friedman RA, Powell CA. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. Am J Respir Crit Care Med. 2005 Sep 15; 172(6):729-37.
      View in: PubMed
    35. Borczuk AC, Taub RN, Hesdorffer M, Hibshoosh H, Chabot JA, Keohan ML, Alsberry R, Alexis D, Powell CA. P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma. Clin Cancer Res. 2005 May 1; 11(9):3303-8.
      View in: PubMed
    36. Shah L, Walter KL, Borczuk AC, Kawut SM, Sonett JR, Gorenstein LA, Ginsburg ME, Steinglass KM, Powell CA. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Cancer. 2004 Oct 1; 101(7):1632-8.
      View in: PubMed
    37. Borczuk AC, Assaad AM, Wang LQ, Walter KL, Powell CA. Non-small cell lung cancer molecular profiles are associated with lung development. Chest. 2004 May; 125(5 Suppl):115S-6S.
      View in: PubMed
    38. Borczuk AC, Shah L, Pearson GD, Walter KL, Wang L, Austin JH, Friedman RA, Powell CA. Molecular signatures in biopsy specimens of lung cancer. Am J Respir Crit Care Med. 2004 Jul 15; 170(2):167-74.
      View in: PubMed
    39. Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, Powell CA. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol. 2003 Nov; 163(5):1949-60.
      View in: PubMed
    40. Kim H, Xu GL, Borczuk AC, Busch S, Filmus J, Capurro M, Brody JS, Lange J, D'Armiento JM, Rothman PB, Powell CA. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol. 2003 Dec; 29(6):694-701.
      View in: PubMed
    41. Powell CA, Spira A, Derti A, DeLisi C, Liu G, Borczuk A, Busch S, Sahasrabudhe S, Chen Y, Sugarbaker D, Bueno R, Richards WG, Brody JS. Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am J Respir Cell Mol Biol. 2003 Aug; 29(2):157-62.
      View in: PubMed
    42. Powell CA, Bueno R, Borczuk AC, Caracta CF, Richards WG, Sugarbaker DJ, Brody JS. Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers. Lung Cancer. 2003 Jan; 39(1):23-9.
      View in: PubMed
    43. Powell CA, Xu G, Filmus J, Busch S, Brody JS, Rothman PB. Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor. Chest. 2002 Mar; 121(3 Suppl):6S-7S.
      View in: PubMed
    44. Powell CA, Caplan CE. Pulmonary function tests in preoperative pulmonary evaluation. Clin Chest Med. 2001 Dec; 22(4):703-14, viii.
      View in: PubMed
    Powell's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067